| pubmed-article:21430561 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21430561 | lifeskim:mentions | umls-concept:C0009462 | lld:lifeskim |
| pubmed-article:21430561 | lifeskim:mentions | umls-concept:C0005823 | lld:lifeskim |
| pubmed-article:21430561 | lifeskim:mentions | umls-concept:C1144465 | lld:lifeskim |
| pubmed-article:21430561 | lifeskim:mentions | umls-concept:C0546881 | lld:lifeskim |
| pubmed-article:21430561 | lifeskim:mentions | umls-concept:C0175630 | lld:lifeskim |
| pubmed-article:21430561 | lifeskim:mentions | umls-concept:C1537044 | lld:lifeskim |
| pubmed-article:21430561 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21430561 | pubmed:dateCreated | 2011-4-8 | lld:pubmed |
| pubmed-article:21430561 | pubmed:abstractText | Clinical trials using cholesteryl ester transfer protein (CETP) inhibitors to raise high-density lipoprotein cholesterol (HDL-C) concentrations reported an 'off-target' blood pressure (BP) raising effect. We evaluated the relations of baseline plasma CETP activity and longitudinal BP change. | lld:pubmed |
| pubmed-article:21430561 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21430561 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21430561 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21430561 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21430561 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21430561 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21430561 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21430561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21430561 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21430561 | pubmed:month | May | lld:pubmed |
| pubmed-article:21430561 | pubmed:issn | 1473-5598 | lld:pubmed |
| pubmed-article:21430561 | pubmed:author | pubmed-author:OrdovasJose... | lld:pubmed |
| pubmed-article:21430561 | pubmed:author | pubmed-author:VasanRamachan... | lld:pubmed |
| pubmed-article:21430561 | pubmed:author | pubmed-author:D'AgostinoRal... | lld:pubmed |
| pubmed-article:21430561 | pubmed:author | pubmed-author:ZachariahJust... | lld:pubmed |
| pubmed-article:21430561 | pubmed:author | pubmed-author:LyassAsyaA | lld:pubmed |
| pubmed-article:21430561 | pubmed:author | pubmed-author:KaurGuneetG | lld:pubmed |
| pubmed-article:21430561 | pubmed:author | pubmed-author:PencinaMichae... | lld:pubmed |
| pubmed-article:21430561 | pubmed:copyrightInfo | © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins | lld:pubmed |
| pubmed-article:21430561 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21430561 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:21430561 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21430561 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21430561 | pubmed:pagination | 863-8 | lld:pubmed |
| pubmed-article:21430561 | pubmed:dateRevised | 2011-10-31 | lld:pubmed |
| pubmed-article:21430561 | pubmed:meshHeading | pubmed-meshheading:21430561... | lld:pubmed |
| pubmed-article:21430561 | pubmed:meshHeading | pubmed-meshheading:21430561... | lld:pubmed |
| pubmed-article:21430561 | pubmed:meshHeading | pubmed-meshheading:21430561... | lld:pubmed |
| pubmed-article:21430561 | pubmed:meshHeading | pubmed-meshheading:21430561... | lld:pubmed |
| pubmed-article:21430561 | pubmed:meshHeading | pubmed-meshheading:21430561... | lld:pubmed |
| pubmed-article:21430561 | pubmed:meshHeading | pubmed-meshheading:21430561... | lld:pubmed |
| pubmed-article:21430561 | pubmed:meshHeading | pubmed-meshheading:21430561... | lld:pubmed |
| pubmed-article:21430561 | pubmed:meshHeading | pubmed-meshheading:21430561... | lld:pubmed |
| pubmed-article:21430561 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21430561 | pubmed:articleTitle | Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the community. | lld:pubmed |
| pubmed-article:21430561 | pubmed:affiliation | Framingham Heart Study, Framingham, MA 01702-5803, USA. | lld:pubmed |
| pubmed-article:21430561 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21430561 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
